Innovator IBD 50 ETF (NYSEARCA:FFTY) Shares Up 2.5% – Time to Buy?

Innovator IBD 50 ETF (NYSEARCA:FFTY) shares rose 2.5% during mid-day trading on Tuesday . The company traded as high as $38.12 and last traded at $38.04. 26,855 shares traded hands during trading, a decline of 58% from the average daily volume of 64,038 shares. The stock had previously closed at $37.12.

Innovator IBD 50 ETF Stock Up 2.5%

The company has a market cap of $81.79 million, a PE ratio of 30.34 and a beta of 1.47. The firm’s fifty day simple moving average is $40.21 and its 200-day simple moving average is $38.50.

Institutional Investors Weigh In On Innovator IBD 50 ETF

Institutional investors and hedge funds have recently bought and sold shares of the stock. NewEdge Advisors LLC acquired a new stake in Innovator IBD 50 ETF during the 1st quarter valued at $306,000. Bank of America Corp DE lifted its position in shares of Innovator IBD 50 ETF by 307.2% in the second quarter. Bank of America Corp DE now owns 12,448 shares of the company’s stock valued at $404,000 after acquiring an additional 9,391 shares in the last quarter. JPMorgan Chase & Co. purchased a new stake in shares of Innovator IBD 50 ETF in the third quarter valued at $478,000. BNP Paribas Financial Markets acquired a new stake in shares of Innovator IBD 50 ETF during the third quarter valued at $1,494,000. Finally, Prosperity Wealth Management Inc. acquired a new stake in shares of Innovator IBD 50 ETF during the third quarter valued at $637,000.

Innovator IBD 50 ETF Company Profile

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.